Jason Haas - Chief Financial Officer at Syros Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
SYRS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jason Haas - trading volume in the past year for Syros Pharmaceuticals, Inc.

Holdings reported by Jason Haas for Syros Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 125K $209K $1.68 Sep 12, 2024 Direct
Restricted Stock Units 26.7K $137K $5.12 Mar 31, 2024 Direct Common Stock

Transactions reported by Jason Haas for Syros Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.